Kinarus-Logo_RGB.jpg
Kinarus Therapeutics Group Reports 2022 Annual Results
May 31, 2023 01:00 ET | Kinarus Therapeutic Holding AG
Publishes Annual Report with Audited Consolidated Financial Results for Year Ended 31 December 2022Clinical efforts re-focused on developing KIN001 for original indications IPF and wet AMDCDIM CHF1.5...
AMD logo black .jpg
AMD to Participate in Bank of America Global Technology Conference
May 24, 2023 16:15 ET | Advanced Micro Devices, Inc.
SANTA CLARA, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced that Dan McNamara, Senior Vice President and General Manager, Server Business, will participate in a fireside...
Assemblée Générale A
Assemblée Générale Annuelle du 13 juin 2023 : Modalités de mise à disposition des documents préparatoires
May 24, 2023 13:00 ET | Pixium Vision
Assemblée Générale Annuelle du 13 juin 2023 : Modalités de mise à disposition des documents préparatoires Paris, 24 mai 2023 - 19h00 CET- Pixium Vision SA (Euronext Growth Paris - FR0011950641),...
Annual Meeting of Sh
Annual Meeting of Shareholders June 13, 2023 / Availability of preparatory documents
May 24, 2023 13:00 ET | Pixium Vision
Annual Meeting of Shareholders June 13, 2023 Availability of preparatory documents Paris, France, May 24, 2023 – 19:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a...
AMD logo black .jpg
AMD to Participate in J.P. Morgan’s 51st Annual Global Technology, Media and Communications Conference
May 15, 2023 16:15 ET | Advanced Micro Devices, Inc.
SANTA CLARA, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced that Jean Hu, Executive Vice President, Chief Financial Officer and Treasurer, will participate in a fireside...
Kinarus-Logo_RGB.jpg
Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
May 11, 2023 01:00 ET | Kinarus Therapeutic Holding AG
Basel, Switzerland, May 10, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
Pixium Vision convoq
Pixium Vision convoque son Assemblée Générale Annuelle le 13 juin 2023
May 10, 2023 13:00 ET | Pixium Vision
Pixium Vision convoque son Assemblée Générale Annuelle le 13 juin 2023 Paris, le 10 mai 2023 – 19 h 00 CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641 - Mnemo: ALPIX), société...
Pixium Vision conven
Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023
May 10, 2023 13:00 ET | Pixium Vision
Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023 Paris, France, May 10, 2023 – 07:00 p.m. CET – Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics...
Kinarus-Logo_RGB.jpg
Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures
May 05, 2023 01:00 ET | Kinarus Therapeutic Holding AG
 Audited full year 2022 annual financial figures due to be reported by end of May 2023 Basel, Switzerland, May 5, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage...
AMD logo black .jpg
AMD Reports First Quarter 2023 Financial Results
May 02, 2023 16:15 ET | Advanced Micro Devices, Inc.
SANTA CLARA, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced revenue for the first quarter of 2023 of $5.4 billion, gross margin of 44%, operating loss of $145 million, net...